These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10997798)

  • 1. Recombinant factor VIIa treatment of bleeding associated with acute renal failure.
    Moisescu E; Ardelean L; Simion I; Mureşan A; Ciupan R
    Blood Coagul Fibrinolysis; 2000 Sep; 11(6):575-7. PubMed ID: 10997798
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of traumatic bleeding with recombinant factor VIIa.
    Kenet G; Walden R; Eldad A; Martinowitz U
    Lancet; 1999 Nov; 354(9193):1879. PubMed ID: 10584732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant factor VIIa in severe uremic bleeding.
    Révész T; Arets B; Bierings M; van den Bos C; Duval E
    Thromb Haemost; 1998 Aug; 80(2):353. PubMed ID: 9716175
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of recombinant factor VIIa in life-threatening bleeding following autologous peripheral blood stem cell transplantation complicated by platelet refractoriness.
    Culligan DJ; Salamat A; Tait J; Westland G; Watson HG
    Bone Marrow Transplant; 2003 Jun; 31(12):1183-4. PubMed ID: 12796803
    [No Abstract]   [Full Text] [Related]  

  • 5. Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies.
    De Fabritiis P; Dentamaro T; Picardi A; Cudillo L; Masi M; Amadori S
    Haematologica; 2004 Feb; 89(2):243-5. PubMed ID: 15003905
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful treatment of an injury bleeding on a patient suffering from mild von Willebrand's disease and predisposition to allergic diseases, with recombinant factor VIIA.
    Alesci S; Krekeler S; Miesbach W
    Haemophilia; 2011 May; 17(3):545-6. PubMed ID: 21070492
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of acute bleeding with recombinant factor VIIa in a patient with IgA deficit receiving anticoagulant therapy.
    Sanchis Cervera J; Andrés Blasco CJ; Mena-Duran AV
    Acta Haematol; 2003; 110(1):51-2. PubMed ID: 12975561
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of bleeding in severe necrotizing pancreatitis with recombinant factor VIIa.
    Svartholm E; Annerhagen V; Länne T
    Anesthesiology; 2002 Jun; 96(6):1528. PubMed ID: 12170074
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of recombinant factor VIIa for major haemorrhage.
    Pugh RJ; Wenstone R; Martlew VJ; Marx G
    Eur J Anaesthesiol; 2005 Jul; 22(7):548-50. PubMed ID: 16045146
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bleeding associated with septic shock treated successfully with recombinant activated factor VII: a case report].
    Del Cojo Peces E; Torrado Criado MD; Macías Pingarrón JP; Negrete Calderón N
    Rev Esp Anestesiol Reanim; 2005 May; 52(5):301-3. PubMed ID: 15968911
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful control of postsurgical bleeding by recombinant factor VIIa in a renal failure patient given low molecular weight heparin and aspirin.
    Ng HJ; Koh LP; Lee LH
    Ann Hematol; 2003 Apr; 82(4):257-8. PubMed ID: 12707733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bleeding after cardiac surgery: the role of recombinant factor VIIa].
    von Heymann C; Spies C; Grubitzsch H; Schönfeld H; Sander M; Volk T
    Hamostaseologie; 2006 Aug; 26(3 Suppl 1):S77-87. PubMed ID: 16953296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of bleeding in severe hemorrhagic pancreatitis with recombinant factor VIIa.
    Schuster R; Lee SJ; Rink D
    Am Surg; 2003 Nov; 69(11):1017-8. PubMed ID: 14627269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of bleeding with recombinant factor VIIa in a patient with extensive burns.
    Bianchi A; Jackson D; Maitz P; Thanakrishnan G
    Thromb Haemost; 2004 Jan; 91(1):203-4. PubMed ID: 14691589
    [No Abstract]   [Full Text] [Related]  

  • 15. Factor VIIa (recombinant) for acute traumatic hemorrhage.
    Patanwala AE
    Am J Health Syst Pharm; 2008 Sep; 65(17):1616-23. PubMed ID: 18714107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unlabeled uses of factor VIIa (recombinant) in pediatric patients.
    Hong I; Stachnik J
    Am J Health Syst Pharm; 2010 Nov; 67(22):1909-19. PubMed ID: 21048207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of acute bleeding episodes with rFVIIa.
    Ingerslev J; Sneppen O; Hvid I; Fredberg U; Kristensen HL; Sindet-Petersen S
    Vox Sang; 1999; 77 Suppl 1():42-6. PubMed ID: 10529687
    [No Abstract]   [Full Text] [Related]  

  • 18. Recombinant factor VIIa use following massive pulmonary hemorrhage after CPB.
    Courtney H
    Paediatr Anaesth; 2009 Mar; 19(3):272. PubMed ID: 19236650
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of factor VII deficiency with recombinant factor VIIa.
    Bauer KA
    Haemostasis; 1996; 26 Suppl 1():155-8. PubMed ID: 8904192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The successful use of recombinant factor VIIa in a patient with vascular-type Ehlers-Danlos syndrome.
    Faber P; Craig WL; Duncan JL; Holliday K
    Acta Anaesthesiol Scand; 2007 Oct; 51(9):1277-9. PubMed ID: 17714577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.